FCM
Farallon Capital Management Portfolio holdings
AUM
$21.3B
1-Year Return
23.12%
This Quarter Return
+5.32%
1 Year Return
+23.12%
3 Year Return
+87.19%
5 Year Return
+183.94%
10 Year Return
+836.54%
AUM
$13.6B
AUM Growth
+$1.6B
(+13%)
Cap. Flow
+$985M
Cap. Flow
% of AUM
7.26%
Top 10 Holdings %
Top 10 Hldgs %
48.35%
Holding
114
New
28
Increased
35
Reduced
22
Closed
19
Top Buys
| 1 |
AABA
Altaba Inc. Common Stock
AABA
|
$767M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
$518M |
| 3 |
XL
XL Group Ltd.
XL
|
$331M |
| 4 |
General Dynamics
GD
|
$316M |
| 5 |
AET
Aetna Inc
AET
|
$200M |
Top Sells
| 1 |
NXP Semiconductors
NXPI
|
$612M |
| 2 |
MON
Monsanto Co
MON
|
$543M |
| 3 |
COL
Rockwell Collins
COL
|
$150M |
| 4 |
ABLX
Ablynx NV American Depositary Shares
ABLX
|
$134M |
| 5 |
CAVM
Cavium, Inc.
CAVM
|
$116M |
Sector Composition
| 1 | Healthcare | 23.41% |
| 2 | Technology | 22.68% |
| 3 | Financials | 17.16% |
| 4 | Communication Services | 13.67% |
| 5 | Industrials | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
NovoCure
NVCR
$1.37B
| $49.8M | 0.31% |
1,590,000
-260,000
| -14% | -$8.14M |
|
|
EVHC
52
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $48M | 0.3% |
1,090,000
+725,000
| +199% | +$31.9M |
|
|
CAVM
53
DELISTED
Cavium, Inc.
CAVM
| $47.1M | 0.29% |
545,000
-1,345,000
| -71% | -$116M |
|
54
Alnylam Pharmaceuticals
ALNY
$59.2B
| $40.9M | 0.25% |
415,000
+45,000
| +12% | +$4.43M |
|
|
MRTX
55
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $36.7M | 0.23% |
743,500
+473,500
| +175% | +$23.3M |
|
56
AB InBev
BUD
$118B
| $36.1M | 0.22% |
+358,533
| New | +$36.1M |
|
|
RC
57
Ready Capital
RC
$705M
| $35.9M | 0.22% |
2,208,239
| – | – |
|
|
HRG
58
DELISTED
HRG Group, Inc.
HRG
| $30M | 0.19% |
2,290,000
-1,750,000
| -43% | -$22.9M |
|
59
Savara
SVRA
$643M
| $25.2M | 0.16% |
2,225,000
| – | – |
|
60
Intellia Therapeutics
NTLA
$1.29B
| $23M | 0.14% |
840,000
+190,000
| +29% | +$5.2M |
|
61
Dynavax Technologies
DVAX
$1.18B
| $22M | 0.14% |
+1,440,000
| New | +$22M |
|
|
PGNX
62
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $21.3M | 0.13% |
+2,651,100
| New | +$21.3M |
|
|
BMS
63
DELISTED
Bemis
BMS
| $18.7M | 0.12% |
442,500
-120,000
| -21% | -$5.07M |
|
64
Codexis
CDXS
$218M
| $16.2M | 0.1% |
+1,125,000
| New | +$16.2M |
|
|
CCXI
65
DELISTED
ChemoCentryx, Inc.
CCXI
| $15.1M | 0.09% |
1,150,000
+200,000
| +21% | +$2.63M |
|
66
Voyager Therapeutics
VYGR
$235M
| $15M | 0.09% |
768,157
-121,843
| -14% | -$2.38M |
|
|
BLCM
67
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $14.8M | 0.09% |
+200,000
| New | +$14.8M |
|
|
APTX
68
DELISTED
Aptinyx Inc. Common Stock
APTX
| $14.4M | 0.09% |
+596,800
| New | +$14.4M |
|
|
AMRN
69
Amarin Corp
AMRN
$317M
| $13.9M | 0.09% |
224,250
-3,750
| -2% | -$232K |
|
70
Larimar Therapeutics
LRMR
$337M
| $13M | 0.08% |
+105,545
| New | +$13M |
|
71
Grifois
GRFS
$6.89B
| $11.9M | 0.07% |
551,304
+158,500
| +40% | +$3.41M |
|
72
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $11.8M | 0.07% |
+845,000
| New | +$11.8M |
|
|
SHPG
73
DELISTED
Shire pic
SHPG
| $11.7M | 0.07% |
+69,547
| New | +$11.7M |
|
|
ZEAL
74
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
| $11.4M | 0.07% |
900,000
+35,000
| +4% | +$444K |
|
75
Zymeworks
ZYME
$1.14B
| $11.2M | 0.07% |
+755,000
| New | +$11.2M |
|